72 results
Search Results
2. Discussion of the papers by Doctors Karnofsky and Law.
3. Formal discussion of Robert J. Lukes' paper, "Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin's disease.
4. Determination of mammalian cell (strain HeLa) inhibition by an agar diffusion technic. II. Paper chromatographic methods.
5. SUMMARY OF INFORMAL DISCUSSIONS ON THE ROLE OF PYRIMIDINE ANTAGONISTS FOLLOWING PAPERS BY DR. PRUSOFF AND DR. CALABRESI.
6. Formal discussion of F. Teillet et al's paper, "a reappraisal of clinical and biological signs in staging of Hodgkin's disease.
7. Discussion of Doctor Greenstein's paper.
8. Discussion of Dr. Huggins' paper: Control of cancers of man by endocrinological methods.
9. On a paper by Nagata, Fukui, Yonezawa and Tagashira: electronic structure and carcinogenic activity of aromatic molecules.
10. The present status of cancer chemotherapy--a summary of papers delivered at the Cherry Hill Conference on "a critical evaluation of cancer chemotherapy".
11. Formal discussion of J. H. Burchenal's paper, "Success and failure in present chemotherapy and the implications of asparaginase".
12. Formal discussion of Brian MacMahon's paper, "epidemiological considerations of staging in Hodgkin's disease".
13. Summary of papers delivered at the Conference on Staging in Hodgkin's Disease (Ann Arbor).
14. Discussion of Dr. Gallagher's paper.
15. Summary of papers delivered at the Conference on Herpesvirus and Cervical Cancer (Key Biscayne, Florida).
16. Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine.
17. Distribution of radioactivity and metabolism of formic acid 2-(4-(5-nitro-2-furyl)-2-14C-2-thiazolyl)hydrazide following oral administration to rats and mice.
18. Guanosine anabolism for biosynthesis of nucleic acids in Novikoff ascites rat tumor cells in culture.
19. Fate of the ring moiety of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in mammalian cells.
20. Nucleotide contents of ascites hepatoma cells and their changes induced by D-galactosamine.
21. Patterns of excretion of methylated purines in hepatocellular carcinoma.
22. Physiological disposition of 1-acetyl-2-picolinoylhydrazine (NSC68626) in rats bearing Walker carcinosarcoma 256.
23. Half-life of N-acetylneuraminic acid in plasma membranes of rat liver and Morris hepatoma 7777.
24. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine in humans.
25. Release of thymidine from x-irradiated spleen in the rabbit as determined by a new bioassay.
26. Actinomycin D: drug concentrations and actions in mouse tissues and tumors.
27. The enzymatic reduction of hydroxyurea to urea by mouse liver.
28. Urinary and biliary excretion of the 2,4-diaminoquinazoline antifolate, methasquin, in rats and dogs.
29. The metabolic interrelationship and physicochemical analysis of C-reactive protein and hepatic catalase.
30. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
31. Metabolism of an antineoplastic methylhydrazine derivative in a P815 mouse neoplasm.
32. Urethan carcinogenesis and nucleic acid metabolism: in vivo incorporation of pyrimidines-14C and urethan-14C into mouse organs.
33. The isolation, characterization, and antigenicity of malignolipin-like material from normal and tumor tissue.
34. Pharmacology of 6-thioguanine in man.
35. Transport and metabolism of glucosamine by cultured Novikoff rat hepatoma cells and effects on nucleotide pools.
36. The ratio of albumin synthesis to total protein synthesis in normal rat liver, in host liver, and in Morris hepatoma 9121.
37. Hormonal effects on thymidine kinase activity in normal rat adrenal and in hormone-dependent adrenal carcinoma.
38. S-adenosylmethionine synthetase activity in some normal rat tissues and transplantable hepatomas.
39. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in formation of putrescine, spermidine, and spermine.
40. A comparison of polypyrimidine fragments in 28 S ribosomal RNA from rat liver and the Novikoff ascites hepatoma.
41. The biotin synthesis of HeLa cells in vitro.
42. Differences in the in vivo alkylation and cross-linking of nitrogen mustard-sensitive and -resistant lines of Lettré-Ehrlich asites tumors.
43. Biological and biochemical differences between tubercidin (7-deazaadenosine) and its 5'-phosphate methyl ester.
44. Metabolic activities of murine carcinoma 755 at various stages of growth.
45. Seryl transfer RNA changes during estrogen-induced phosvitin synthesis and a unique seryl transfer RNA modification.
46. In vivo interaction of urethan with nucleic acids and proteins.
47. Isolation and degradation of DNA from cells treated with tritium-labeled 7,12-dimethylbenz(a)anthracene: studies on the nature of the binding of this carcinogen to DNA.
48. Metabolism and biological effects of N 6 -( 2 -isopentenyl)-adenosine on a cell line derived from circulating leukocytes of a patient with chronic myelogenous leukemia.
49. Fate of tetrahydrohomofolate in mice.
50. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.